Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: J Clin Epidemiol. 2016 Feb 27;73:119–127. doi: 10.1016/j.jclinepi.2015.08.036

Table 2.

PROMIS Depression/Anxiety Scores in Cancer Subsamples

Cancer-Better
(n = 70)
Cancer-Same
(n = 135)
Cancer-Worse
(n = 38)
Depression
Baseline 50.3 (48.6, 51.9) 49.6 (48.3, 50.9) 54.8 (52.9, 56.7)
Follow-up 48.2 (46.5, 49.9) 48.9 (47.6, 50.2) 57.8 (55.9, 59.7)
Change −2.1 (−3.4, −0.7)* −0.7 (−1.6, 0.2) 3.0 (1.7, 4.4)**
Anxiety
n = 76 n = 129 n = 41
Baseline 53.8 (52.2, 55.4) 51.7 (50.4, 53.0) 58.5 (56.6, 60.4)
Follow-up 51.1 (49.5, 52.7) 50.9 (49.7, 52.2) 60.4 (58.5, 62.3)
Change −2.7 (−4.1, −1.2)** −0.7 (−1.7, 0.2) 1.9 (0.2, 3.6)*

Entries in the table denote the least squares mean and 95% confidence interval, as estimated in the mixed models. Cancer subgroups were created using responses to the question, “Since the last time you filled out a questionnaire, your level of depression [anxiety] is…,” assessed at follow-up. The sum of the sample sizes for the change groups (n = 278) represents 78% of the enrolled cancer sample.

*

p<0.05

**

p≤ 0.001